Skip to content
10-Q

Quarterly Report

AGIOS PHARMACEUTICALS, INC. AGIO

0001439222-25-000116

← back to feed
Filed
Oct 30, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 24, 2025 58.31M sh
Shares Diluted Q3 2025 · Sep 30, 2025 58.14M sh
Shares Diluted Q3 2025 · Sep 30, 2025 57.85M sh
Shares Diluted Q3 2025 · Sep 30, 2024 58.43M sh
Shares Diluted Q3 2025 · Sep 30, 2024 57.58M sh
Capex Q3 2025 · Sep 30, 2025 $3.2M
Capex Q3 2025 · Sep 30, 2024 $718K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$276.76M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$256.67M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $92.71M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $76.25M
Stockholders Equity Q3 2025 · Sep 30, 2025 $1.28B
Stockholders Equity Q3 2025 · Jun 30, 2025 $1.37B
Stockholders Equity Q3 2025 · Mar 31, 2025 $1.47B
Stockholders Equity Q3 2025 · Dec 31, 2024 $1.54B
Stockholders Equity Q3 2025 · Sep 30, 2024 $1.63B
Stockholders Equity Q3 2025 · Jun 30, 2024 $660.51M
Stockholders Equity Q3 2025 · Mar 31, 2024 $743.92M
Stockholders Equity Q3 2025 · Dec 31, 2023 $811.02M
Current Liabilities Q3 2025 · Sep 30, 2025 $74.76M
Current Liabilities Q3 2025 · Dec 31, 2024 $81.16M
Total Liabilities Q3 2025 · Sep 30, 2025 $101.38M
Total Liabilities Q3 2025 · Dec 31, 2024 $122.24M
Current Assets Q3 2025 · Sep 30, 2025 $1.03B
Current Assets Q3 2025 · Dec 31, 2024 $965.6M
Total Assets Q3 2025 · Sep 30, 2025 $1.39B
Total Assets Q3 2025 · Dec 31, 2024 $1.66B
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.78
Eps Diluted Q3 2025 · Sep 30, 2025 −$5.27
Eps Diluted Q3 2025 · Sep 30, 2024 $16.22
Eps Diluted Q3 2025 · Sep 30, 2024 $13.38
Eps Basic Q3 2025 · Sep 30, 2025 −$1.78
Eps Basic Q3 2025 · Sep 30, 2025 −$5.27
Eps Basic Q3 2025 · Sep 30, 2024 $16.65
Eps Basic Q3 2025 · Sep 30, 2024 $13.58
Sga Expense Q3 2025 · Sep 30, 2025 $41.27M
Sga Expense Q3 2025 · Sep 30, 2025 $128.67M
Sga Expense Q3 2025 · Sep 30, 2024 $38.54M
Sga Expense Q3 2025 · Sep 30, 2024 $105.09M
Rd Expense Q3 2025 · Sep 30, 2025 $86.8M
Rd Expense Q3 2025 · Sep 30, 2025 $251.48M
Rd Expense Q3 2025 · Sep 30, 2024 $72.46M
Rd Expense Q3 2025 · Sep 30, 2024 $218.48M
Net Income Q3 2025 · Sep 30, 2025 −$103.43M
Net Income Q3 2025 · Sep 30, 2025 −$304.74M
Net Income Q3 2025 · Jun 30, 2025 −$112.02M
Net Income Q3 2025 · Mar 31, 2025 −$89.29M
Net Income Q3 2025 · Sep 30, 2024 $947.92M
Net Income Q3 2025 · Sep 30, 2024 $770.25M
Net Income Q3 2025 · Jun 30, 2024 −$96.12M
Net Income Q3 2025 · Mar 31, 2024 −$81.55M
Operating Income Q3 2025 · Sep 30, 2025 −$116.87M
Operating Income Q3 2025 · Sep 30, 2025 −$350.55M
Operating Income Q3 2025 · Sep 30, 2024 −$102.81M
Operating Income Q3 2025 · Sep 30, 2024 −$300.7M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $1.68M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $4.47M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $783K
Cost Of Revenue Q3 2025 · Sep 30, 2024 $2.91M
Revenue Q3 2025 · Sep 30, 2025 $12.88M
Revenue Q3 2025 · Sep 30, 2025 $34.06M
Revenue Q3 2025 · Sep 30, 2024 $8.96M
Revenue Q3 2025 · Sep 30, 2024 $25.77M